CADTH has conducted an Environmental Scan to support a health technology assessment project that regarded the use of stereotactic ablative radiotherapy (SABR) for the treatment of oligometastatic...

A number of biosimilar drugs are emerging in Canada. As these drugs cannot be considered direct replacements for the innovator biologics they are based on, their adoption in clinical practice is not...